1. Home
  2. RDHL vs GITS Comparison

RDHL vs GITS Comparison

Compare RDHL & GITS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • GITS
  • Stock Information
  • Founded
  • RDHL 2009
  • GITS 2018
  • Country
  • RDHL Israel
  • GITS South Korea
  • Employees
  • RDHL N/A
  • GITS N/A
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • GITS
  • Sector
  • RDHL Health Care
  • GITS
  • Exchange
  • RDHL Nasdaq
  • GITS Nasdaq
  • Market Cap
  • RDHL 3.8M
  • GITS 3.4M
  • IPO Year
  • RDHL N/A
  • GITS N/A
  • Fundamental
  • Price
  • RDHL $1.99
  • GITS $2.02
  • Analyst Decision
  • RDHL
  • GITS
  • Analyst Count
  • RDHL 0
  • GITS 0
  • Target Price
  • RDHL N/A
  • GITS N/A
  • AVG Volume (30 Days)
  • RDHL 214.4K
  • GITS 2.9M
  • Earning Date
  • RDHL 04-10-2025
  • GITS 07-15-2025
  • Dividend Yield
  • RDHL N/A
  • GITS N/A
  • EPS Growth
  • RDHL N/A
  • GITS N/A
  • EPS
  • RDHL N/A
  • GITS N/A
  • Revenue
  • RDHL $8,042,999.00
  • GITS N/A
  • Revenue This Year
  • RDHL $381.91
  • GITS N/A
  • Revenue Next Year
  • RDHL N/A
  • GITS N/A
  • P/E Ratio
  • RDHL N/A
  • GITS N/A
  • Revenue Growth
  • RDHL 23.17
  • GITS N/A
  • 52 Week Low
  • RDHL $1.71
  • GITS $0.87
  • 52 Week High
  • RDHL $20.28
  • GITS $9.78
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 51.03
  • GITS N/A
  • Support Level
  • RDHL $1.82
  • GITS N/A
  • Resistance Level
  • RDHL $1.93
  • GITS N/A
  • Average True Range (ATR)
  • RDHL 0.08
  • GITS 0.00
  • MACD
  • RDHL 0.04
  • GITS 0.00
  • Stochastic Oscillator
  • RDHL 100.00
  • GITS 0.00

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.

About GITS Global Interactive Technologies Inc. Common Stock

Global Interactive Technologies Inc, formerly Hanryu Holdings Inc is the creator of the engaging social media platform, FANTOO. Through FANTOO, it provides a multi-media platform for its users to interact with other like-minded users, share their appreciation of various types of entertainment and cultures, create their content, enjoy content, and engage in commerce.

Share on Social Networks: